The importance of the estrogen receptor (ER) in breast cancer development make it a prominent target for therapy. Current treatments, however, have limited effectiveness hence the definition of new therapeutic targets is vital.
Guest Lecture by Dr. Luke Gaughan, Newcastle University
The title of Dr. Gaughan's talk is: "Examining the role of histone demethylase enzymes in estrogen receptor regulation"
Published Nov. 21, 2011 2:45 PM
- Last modified Nov. 6, 2012 12:27 PM